Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to assess basic feasibility, safety, and performance of an EUS access device in patients with malignant biliary obstruction who are indicated to receive EUS-guided h...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boston Scientific Corporation
NCT05169398 · Malignant Biliary Obstruction
NCT06653192 · Malignant Biliary Obstruction, Pancreatic Cancer, and more
NCT03000855 · Malignant Biliary Obstruction
NCT05804201 · Malignant Biliary Obstruction
NCT05220475 · Malignant Biliary Obstruction
Ghent University Hospital
Ghent
Georges Pompidou European Hospital
Paris
Asian Institute of Gastroenterology
Hyderabad, Telangana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions